by | Feb 21, 2020 | Ladenson, Jack
—
Antibody codes: 2B1.9 (3268) and 2F6.6
Publication: Bodor GS, Porter S, Landt Y, Ladenson JH. Development of monoclonal antibodies for an assay of cardiac troponin-I and preliminary results in suspected cases of myocardial infarction. Clin Chem. 1992 Nov;38(11):2203-14.
Antibody codes: 5…
by | Feb 20, 2020 | Ladenson, Jack, Landt, Yvonne, Laterza, Omar, Modur, Vijay
— Technology Description
Researchers in Prof. Jack Ladenson’s laboratory have discovered biomarkers and associated antibodies for Alzheimer’s disease (AD) that could be used for early/presymptomatic diagnosis or in clinical trials for AD drugs.
This patented technology is based on the i…
by | Feb 20, 2020 | Ladenson, Jack, Porter, Sharon
— Analyte: Transferrin Receptor (CD71)
Antibody codes: 2B7.4 (4065) and 2F6.3 (4077)
Publications:
by | Feb 20, 2020 | Ladenson, Jack
— Analyte: Myoglobin
Antibody codes:
Notes: Suitable for two-site immunoassay
Publication: Silva DP Jr, Landt Y, Porter SE, Ladenson JH. Development and application of monoclonal antibodies to human cardiac myoglobin in a rapid fluorescence immunoassay. Clin Chem. 1991 Aug;37(8):1356-64.
by | Feb 20, 2020 | Ladenson, Jack
— Analyte: Calmodulin
Antibody code: 2D1.15
Publication: Sacks DB, Porter SE, Ladenson JH, McDonald JM. Monoclonal antibody to calmodulin: development, characterization, and comparison with polyclonal anti-calmodulin antibodies. Anal Biochem. 1991 May 1;194(2):369-77
by | Feb 20, 2020 | Ladenson, Jack, Landt, Yvonne, Laterza, Omar, Modur, Vijay
— Technology Description
Researchers in Prof. Jack Ladenson’s laboratory have discovered biomarkers and associated antibodies for Alzheimer’s disease (AD) that could be used for early/presymptomatic diagnosis or in clinical trials for AD drugs.
This patented technology is based on the i…